Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Timed 25-Foot Walk: Direct evidence that improving 20% or greater is clinically meaningful in MS.
Targeting Potassium Channels Kv1.3 and KC a 3.1: Routes to Selective Immunomodulators in Autoimmune Disorder Treatment?
Muscle oxygen consumption by NIRS and mobility in multiple sclerosis patients.
Myelin membrane assembly is driven by a phase transition of myelin basic proteins into a cohesive protein meshwork.
Estrogen Mediates Neuroprotection and Anti-Inflammatory Effects during EAE through ERα Signaling on Astrocytes But Not through ERβ Signaling on Astrocytes or Neurons.
ACTH protects mature oligodendroglia from excitotoxic and inflammation-related damage in vitro.
Combining genetic mapping with genome-wide expression in experimental autoimmune encephalomyelitis highlights a gene network enriched for T cell functions and candidate genes regulating autoimmunity.
Respiratory tract rather than cutaneous atopic allergy inversely associate with multiple sclerosis: A case-control study.
AQP4 antibody serostatus: Is its luster being lost in the management and pathogenesis of NMO?
Vitamin d and long-term memory in multiple sclerosis.
Detecting cognitive dysfunction in a busy multiple sclerosis clinical setting: a computer generated approach.
Diagnostic problems in "clinically definite" multiple sclerosis patients with normal CSF and multiple MRI abnormalities.
Systematic review of occupational therapy-related interventions for people with multiple sclerosis: part 1. Activity and participation.
Bilateral Optic Neuritis due to Malaria.
Certified occupational therapy assistants.
Translation, cross-cultural adaptation and validation of the Portuguese version of the DYMUS questionnaire for the assessment of dysphagia in multiple sclerosis.
Maintenance percutaneous posterior nerve stimulation for refractory lower urinary tract symptoms in patients with multiple sclerosis.
Diagnosis and therapy of acute disseminated encephalomyelitis and its variants.
The magnetic resonance imaging spectrum of Pelizaeus-Merzbacher disease: A multicenter study of 19 patients.
Retinal Damage and Vision Loss in African-American Multiple Sclerosis Patients.
Uric acid in relapsing-remitting multiple sclerosis: a 2-year longitudinal study.
Anti-muscarinic adjunct therapy accelerates functional human oligodendrocyte repair.
Apcdd1 stimulates oligodendrocyte differentiation after white matter injury.
Does fatigue complaint reflect memory impairment in multiple sclerosis?
Central nervous system involvement in primary Sjogren`s syndrome manifesting as multiple sclerosis.
Pages
« first
‹ previous
…
506
507
508
509
510
511
512
513
514
…
next ›
last »